Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CA1 | P00915 | 12/20 | 0.36 |
| ▸ | CA2 | P00918 | 12/20 | 0.36 |
| ▸ | CA9 | Q16790 | 8/20 | 0.36 |
| ▸ | CA12 | O43570 | 2/20 | 0.35 |
| ▸ | CA3 | P07451 | 2/20 | 0.35 |
| ▸ | CA4 | P22748 | 2/20 | 0.35 |
| ▸ | CA6 | P23280 | 2/20 | 0.35 |
| ▸ | CA5A | P35218 | 2/20 | 0.35 |
| ▸ | CA7 | P43166 | 2/20 | 0.35 |
| ▸ | CA14 | Q9ULX7 | 2/20 | 0.35 |
| ▸ | CA5B | Q9Y2D0 | 2/20 | 0.35 |
| ▸ | LMNA | P02545 | 2/20 | 0.32 |
| ▸ | SLC6A6 | P31641 | 1/20 | 0.32 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.32 |
| ▸ | BLM | P54132 | 1/20 | 0.32 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.30 |
| ▸ | USP2 | O75604 | 1/20 | 0.30 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.30 |
| ▸ | MMP9 | P14780 | 1/20 | 0.30 |
| ▸ | ALOX15 | P16050 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL6014638 | 0.87 | CA1 (0.46) | CA1CA2CA9CA12CA3 | |
| SCHEMBL27897320 | 0.83 | — | — | |
| SCHEMBL8506764 | 0.81 | CA1 (0.46) | CA1CA2CA9CA12CA3 | |
| Ammonia Solution, Strong SCHEMBL27943704 | 0.81 | USP2 (0.36) | CA1CA2USP2TSHR | |
| SCHEMBL1856656 | 0.80 | CA1 (0.36) | CA1CA2CA9CA12CA3 | |
| SCHEMBL700982 | 0.79 | CA1 (0.50) | CA1CA2CA9CA12CA3 | |
| SCHEMBL1176428 | 0.79 | CA1 (0.61) | CA1CA2CA9CA12CA3 | |
| SCHEMBL27632893 | 0.79 | LMNA (0.35) | LMNASLC6A6CYP2C19BLM | |
| SCHEMBL2173072 | 0.78 | CA1 (0.59) | CA1CA2CA9CA12CA3 | |
| SCHEMBL7512081 | 0.78 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 209 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20250059128-A1 | PROCESSES AND CATAYLST SYSTEMS FOR PRODUCING MONOETHANOLAMINE FROM GLYCOLALDEHYDE | ARCHER DANIELS MIDLAND CO (US) | 2025-02-20 | — | — | US | claimed |
| US-12162817-B2 | Processes and catalyst systems for producing monoethanolamine from glycolaldehyde | ARCHER-DANIELS-MIDLAND COMPANY (US) | 2024-12-10 | — | — | US | claimed |
| CN-112601733-B | Method and catalyst system for producing monoethanolamine from glycolaldehyde | 阿彻丹尼尔斯米德兰德公司 | 2023-10-27 | — | — | CN | claimed |
| CN-114989111-B | Synthetic method for preparing 2-mercaptothiazoline | 广州市三珍商贸有限公司 | 2023-03-28 | — | — | CN | claimed |
| CN-114989111-A | Synthetic method for preparing 2-mercaptothiazoline | 广州市三珍商贸有限公司 | 2022-09-02 | — | — | CN | claimed |
| US-20210309604-A1 | PROCESSES AND CATAYLST SYSTEMS FOR PRODUCING MONOETHANOLAMINE FROM GLYCOLALDEHYDE | ARCHER DANIELS MIDLAND COMPANY (US) | 2021-10-07 | — | — | US | claimed |
| EP-3830071-A1 | PROCESSES AND CATAYLST SYSTEMS FOR PRODUCING MONOETHANOLAMINE FROM GLYCOLALDEHYDE | Archer Daniels Midland Company (US) | 2021-06-09 | — | — | EP | claimed |
| CN-107722953-B | Preparation method of branched polyethyleneimine and shale intercalation inhibitor | 西南石油大学 | 2020-02-11 | — | — | CN | claimed |
| WO-2020028322-A1 | PROCESSES AND CATAYLST SYSTEMS FOR PRODUCING MONOETHANOLAMINE FROM GLYCOLALDEHYDE | ARCHER DANIELS MIDLAND COMPANY (US) | 2020-02-06 | — | — | WO | claimed |
| CN-105152985-B | Monoethanolamine produces the cyclic process of taurine | 胡松洲 | 2018-03-27 | — | — | CN | claimed |
| EP-2699626-A1 | CHEMICALLY MODIFIED CELLULOSE FIBROUS MESHES FOR USE AS TISSUE ENGINEERING SCAFFOLDS | University of Massachusetts Medical School (US) | 2014-02-26 | — | — | EP | claimed |
| WO-2012141938-A1 | CHEMICALLY MODIFIED CELLULOSE FIBROUS MESHES FOR USE AS TISSUE ENGINEERING SCAFFOLDS | UNIVERSITY OF MASSACHUSETTS MEDICAL SCHOOL (US) | 2012-10-18 | — | — | WO | claimed |
| EP-1064013-A4 | $i(IN VITRO) FORMATION OF CONGOPHILIC MALTESE-CROSS AMYLOID PLAQUES TO IDENTIFY ANTI-PLAQUE THERAPEUTICS FOR THE TREATMENT OF ALZHEIMER'S AND PRION DISEASES | UNIV WASHINGTON (US) | 2005-05-11 | — | — | EP | claimed |
| EP-1064013-A1 | $i(IN VITRO) FORMATION OF CONGOPHILIC MALTESE-CROSS AMYLOID PLAQUES TO IDENTIFY ANTI-PLAQUE THERAPEUTICS FOR THE TREATMENT OF ALZHEIMER'S AND PRION DISEASES | University of Washington (US) | 2001-01-03 | — | — | EP | claimed |
| WO-1999045947-A9 | IN VITRO FORMATION OF CONGOPHILIC MALTESE-CROSS AMYLOID PLAQUES TO IDENTIFY ANTI-PLAQUE THERAPEUTICS FOR THE TREATMENT OF ALZHEIMER'S AND PRION DISEASES | UNIV WASHINGTON (US) | 2000-03-02 | — | — | WO | claimed |
| WO-1999045947-A1 | IN VITRO FORMATION OF CONGOPHILIC MALTESE-CROSS AMYLOID PLAQUES TO IDENTIFY ANTI-PLAQUE THERAPEUTICS FOR THE TREATMENT OF ALZHEIMER'S AND PRION DISEASES | UNIVERSITY OF WASHINGTON (US) | 1999-09-16 | — | — | WO | claimed |
| US-5643562-A | ANTIDEPOSIT AGENTS FOR PROTEINS FOR MEDICAL DIAGNOSIS OF DISEASES | QUEEN'S UNIVERSITY OF KINGSTON (CA) | 1997-07-01 | — | — | US | claimed |
| CN-1043158-A | Amino-functional compounds as builders/dispersants in detergent compositions | PROCTER & GAMBLE (US) | 1990-06-20 | — | — | CN | claimed |
| US-4618716-A | AND AMMONIA OR ETHYLENE POLYAMINE | AIR PRODUCTS AND CHEMICALS, INC. (US) | 1986-10-21 | — | — | US | claimed |
| US-4324724-A | Manufacture of polyalkylenepolyamines | BASF AKTIENGESELLSCHAFT (DE) | 1982-04-13 | — | — | US | claimed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-12162817-B2 | Processes and catalyst systems for producing monoethanolamine from glycolaldehyde | NAAA, PNMT, GMDS | CA1 480/4885CA2 1825/4885CA9 464/4885 |
| US-20250059128-A1 | PROCESSES AND CATAYLST SYSTEMS FOR PRODUCING MONOETHANOLAMINE FROM GLYCOLALDEHYDE | DLST, CEPT1, AADAT | CA1 445/4885CA2 1009/4885CA9 726/4885 |
| US-20210309604-A1 | PROCESSES AND CATAYLST SYSTEMS FOR PRODUCING MONOETHANOLAMINE FROM GLYCOLALDEHYDE | DLST, CEPT1, AADAT | CA1 445/4885CA2 1009/4885CA9 726/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.